Uterine fibroids are benign tumors in the uterus that can cause prolonged, heavy menstrual bleeding that can be severe enough to cause anemia or require transfusion, disabling pelvic pain and pressure, urinary frequency, pain during intercourse, miscarriage and interference with fertility. Twenty to 40 percent of women age 35 and older have uterine fibroids of a significant size. African-American women are at a higher risk for fibroids: as many as 50 percent have fibroids of a significant size.
Previous studies have already shown UFE, also referred to as uterine artery embolization or UAE, to be a safe and effective treatment compared to hysterectomy; however, UFE offers less risk, less pain and a shorter recovery time compared to surgery, said Spies. Pioneered and performed by interventional radiologists, UFE blocks tiny blood vessels that feed fibroids, causing the tumor to die and symptoms to subside. An interventional radiologist uses imaging to guide a thin catheter to the uterine artery and then releases tiny particles, the size of a grain of sand, into blood vessels feeding the fibroid, cutting off its blood flow and causing it to shrink and its symptoms to subside. UFE is a safe, effective, established treatment that has been widely available for years and is covered by insurance.
For the first time, researchers confirmed that uterine fibroid embolization does indeed control and relieve many lower urinary tract problemssuch as urinary frequency and/or urgency and urinary retentionusing standardized measures of urinary symptoms, said Spies. This prospective study included 46 women (average age of 44) with symptomatic fibroids who had lower urinary tract symptoms and underwent uterine fibroid embolization between March 2008 and May 2010. All subjects underwent a pre-procedure pelvic MRI and completed validated
'/>"/>
| Contact: Maryann Verrillo mverrillo@sirweb.org 703-460-5572 Society of Interventional Radiology Source:Eurekalert |